Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Endra Life Sciences Inc (NQ: NDRA )

0.6669 USD -0.0231 (-3.35%)
Streaming Delayed Price Updated: 3:15 PM EST, Jan 18, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 152,955
Open 0.7400
Bid (Size) 0.6600 (1)
Ask (Size) 0.6669 (3)
Prev. Close 0.6900
Today's Range 0.6511 - 0.7498
52wk Range 0.6400 - 3.100
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
ENDRA Life Sciences to Present at the H.C. Wainwright BioConnect Virtual Conference
ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of enhanced ultrasound technologies, announces that management will present a company overview at the H.C. Wainwright BioConnect Virtual... 
From Business Wire News Releases
ENDRA Life Sciences Announces New Clinical Study Partnership with King’s College Hospital, London
ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of enhanced ultrasound technologies, today announced that King’s College Hospital, London (KCH) is now partnering with ENDRA for a clinical... 
From Business Wire News Releases

Performance

YTD
-9.85%
-9.85%
1 Month
-12.37%
-12.37%
3 Month
-58.83%
-58.83%
6 Month
-61.67%
-61.67%
1 Year
-61.67%
-61.67%

More News

Read More
ENDRA Life Sciences Expands Pharmaceutical Partnerships with VGI Health Technology to Provide TAEUS for Patient Screening and Biomarker Measurement for Phase 2 Study
From Business Wire News Releases
ENDRA Life Sciences Further Strengthens TAEUS® System Intellectual Property with Issuance of 22nd and 23rd U.S. Patents
From Business Wire News Releases
ENDRA Life Sciences to Participate in Two Upcoming Investment Conferences
From ACCESSWIRE
ENDRA Life Sciences Reports Third Quarter 2021 Financial Results and Provides Business Update
From Business Wire News Releases
ENDRA Life Sciences Reports Second Quarter 2021 Financial Results and Provides Business Update
From ACCESSWIRE
ENDRA Life Sciences to Report Third Quarter 2021 Financial Results on November 15, 2021
From Business Wire News Releases
ENDRA Life Sciences Further Strengthens TAEUS® System Intellectual Property Protection with Issuance of 21st U.S. Patent
From Business Wire News Releases
ENDRA Life Sciences to Report Second Quarter 2021 Financial Results on August 12, 2021
From ACCESSWIRE
ENDRA Life Sciences to Participate in the H.C. Wainwright 5th Annual NASH Investor Conference
From Business Wire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.